MedPath

Phase II study of elental for chemotherapy induced mucositis oral and nutritional disturbance

Phase 2
Recruiting
Conditions
cancer chemotherapy induced mucositis oral and nutritional disturbance
Registration Number
JPRN-UMIN000009298
Lead Sponsor
Aizawa Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1)severe symptom with cancer 2)difficult to take elental due to other gastro intestinal symptoms 3)recieve other treatment for oral mucositis 4)physician judged inadequate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath